483 Taro Pharmaceuticals U.S.A. Mar 2012

483 Taro Pharmaceuticals U.S.A. Mar 2012

Sony Mathews FDA$119.00 - Available Now

FDA investigators audited the Taro Pharmaceuticals U.S.A. - Hawthorne, NY, United States facility and issued inspectional observations (via FDA 483) on 08 Mar 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Mar 2012
  • Location: Hawthorne, United States
  • FEI: 2435212
Add To Cart